drugset
drugset / Trial / NCT01774032

H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older

NCT01774032 ↗

Phase 3 Completed 91 enrolled Alachua Government Services, Inc.
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to obtain immunogenicity and safety data of an H5N1 pandemic influenza vaccine in a Japanese elderly population aged 65 years and older.

Timeline

Start
2013-03
Primary completion
2013-06
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject H5N1 Influenza Vaccine Vaccine 0.5 ml Intramuscular

Indications

influenza